Catalyst Wire Dossier Catalyst Wire Dossier

Insuman

Insulin human · Sanofi-aventis Deutschland GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Insuman, covering 2026-03-05 to 2026-03-05. Get the full timeline:

Most recent: EMA Authorised: Insuman (Insulin human) — Sanofi-aventis Deutschland GmbH

See pricing